Liver fibrosis score, physical frailty, and the risk of dementia in older adults: The Italian Longitudinal Study on Aging
- PMID: 32864415
- PMCID: PMC7443742
- DOI: 10.1002/trc2.12065
Liver fibrosis score, physical frailty, and the risk of dementia in older adults: The Italian Longitudinal Study on Aging
Abstract
Introduction: Liver fibrosis increases progressively with aging and has been associated with poorer cognitive performance in middle-aged and older adults. We investigated the relationships between a non-invasive score for advanced liver fibrosis (non-alcoholic fatty liver disease [NAFLD] fibrosis score [NFS]) and dementia risk. We also assessed physical frailty, a common geriatric condition which is associated to dementia. We tested the joint effects of physical frailty and fibrosis on dementia incidence.
Methods: A total of 1061 older adults (65 to 84 years), from the Italian Longitudinal Study on Aging, were prospectively evaluated for the risk of dementia in a period between 1992 and 2001. Liver fibrosis was defined according to the NFS. Physical frailty was assessed according to the Fried's criteria. Cox proportional hazards models were used to estimate the short- and long-term risk of overall dementia, associated to the NFS, testing the effect modifier of physical frailty status.
Results: Older adults with only high NFS (F3-F4) did not exhibit a significant increased risk of overall dementia. Over 8 years of follow-up, frail older adults with high NFS had an increased risk of overall dementia (hazard ratio [HR]: 4.23; 95% confidence interval [CI]: 1.22 to 14.70, P = .023). Finally, physically frail older adults with low albumin serum levels (albumin < 4.3 g/dL) and with advanced liver fibrosis (F3-F4 NFS) compared to those with lower liver fibrosis score (F0-F2 NFS) were more likely to have a higher risk of overall dementia in a long term-period (HR: 16.42; 95% CI: 1.44 to 187.67, P = .024).
Discussion: Advanced liver fibrosis (F3-F4 NFS) could be a long-term predictor for overall dementia in people with physical frailty. These findings should encourage a typical geriatric, multidisciplinary assessment which accounts also for the possible co-presence of frail condition in older adults with chronic liver disease and liver fibrosis.
Keywords: NAFLD fibrosis score; dementia; frailty; older adults; population‐based study.
© 2020 The Authors. Alzheimer's & Dementia: Translational Research & Clinical Interventions published by Wiley Periodicals LLC on behalf of Alzheimer's Association.
Conflict of interest statement
The authors report no competing interests.
Figures
Similar articles
-
High NAFLD fibrosis score in non-alcoholic fatty liver disease as a predictor of carotid plaque development: a retrospective cohort study based on regular health check-up data in China.Ann Med. 2021 Dec;53(1):1621-1631. doi: 10.1080/07853890.2021.1974081. Ann Med. 2021. PMID: 34498502 Free PMC article.
-
Reversible Cognitive Frailty, Dementia, and All-Cause Mortality. The Italian Longitudinal Study on Aging.J Am Med Dir Assoc. 2017 Jan;18(1):89.e1-89.e8. doi: 10.1016/j.jamda.2016.10.012. J Am Med Dir Assoc. 2017. PMID: 28012505
-
Subjective Cognitive Decline as a predictor of Frailty in older adults: Hellenic Longitudinal Investigation of Aging and Diet study (HELIAD).J Frailty Aging. 2023;12(3):198-207. doi: 10.14283/jfa.2023.28. J Frailty Aging. 2023. PMID: 37493380
-
Oral frailty as a risk factor for mild cognitive impairment in community-dwelling older adults: Kashiwa study.Exp Gerontol. 2023 Feb;172:112075. doi: 10.1016/j.exger.2022.112075. Epub 2022 Dec 26. Exp Gerontol. 2023. PMID: 36581224 Review.
-
Social frailty increases the risk of all-cause mortality: A longitudinal analysis of the English Longitudinal Study of Ageing.Exp Gerontol. 2022 Oct 1;167:111901. doi: 10.1016/j.exger.2022.111901. Epub 2022 Jul 20. Exp Gerontol. 2022. PMID: 35870753 Review.
Cited by
-
Frailty in metabolic syndrome, focusing on nonalcoholic fatty liver disease.Ann Gastroenterol. 2022 May-Jun;35(3):234-242. doi: 10.20524/aog.2022.0705. Epub 2022 Mar 25. Ann Gastroenterol. 2022. PMID: 35599934 Free PMC article. Review.
-
Association of chronic liver disease with cognition and brain volumes in two randomized controlled trial populations.J Neurol Sci. 2022 Mar 15;434:120117. doi: 10.1016/j.jns.2021.120117. Epub 2021 Dec 23. J Neurol Sci. 2022. PMID: 34959080 Free PMC article. Clinical Trial.
-
Association of non-alcoholic fatty liver disease with incident dementia later in life among elder adults.Clin Mol Hepatol. 2022 Jul;28(3):510-521. doi: 10.3350/cmh.2021.0332. Epub 2022 Mar 17. Clin Mol Hepatol. 2022. PMID: 35299291 Free PMC article.
-
The Surreptitious Burden of Nonalcoholic Fatty Liver Disease in the Elderly in the Asia-Pacific Region: An Insight from the Global Burden of Disease Study 2019.J Clin Med. 2023 Oct 11;12(20):6456. doi: 10.3390/jcm12206456. J Clin Med. 2023. PMID: 37892594 Free PMC article.
-
The Metabolic Impact of Nonalcoholic Fatty Liver Disease on Cognitive Dysfunction: A Comprehensive Clinical and Pathophysiological Review.Int J Mol Sci. 2024 Mar 15;25(6):3337. doi: 10.3390/ijms25063337. Int J Mol Sci. 2024. PMID: 38542310 Free PMC article. Review.
References
-
- Younossi ZM, Stepanova M, Afendy M. Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008. Clin Gastroenterol Hepatol. 2011;9:524‐530.e1. quiz e60. - PubMed
-
- Frith J, Day CP, Henderson E, Burt AD, Newton JL. Non‐alcoholic fatty liver disease in older people. Gerontology. 2009;55:607‐613. - PubMed
-
- Caballeria L, Pera G, Arteaga I, et al. High prevalence of liver fibrosis among european adults with unknown liver disease: a population‐based study. Clin Gastroenterol Hepatol. 2018;16:1138‐1145.e5. - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous